Manufacturers: WTO/TRIPS Waiver Will Not Solve Crisis
Washington, D.C. – Following the announcement by the United States Trade Ambassador that the Biden administration will support waiving intellectual property protections for COVID-19 vaccines, National Association of Manufacturers President and CEO Jay Timmons released the following statement:
“We are all horrified by the images that we are seeing in India and in other places around the world hard-hit by COVID-19. The proposed WTO/TRIPS waiver would not solve this crisis and would exacerbate the core manufacturing and distribution challenges, as well as introduce serious new safety concerns.
“Rather than rushing to suspend critical protections and standards, investing in even greater production capacity would result in expanded vaccine access. Pharmaceutical manufacturers continue to work around the clock to help the world get armed against COVID-19. We should do everything possible to build on that heroic work, not undermine the protections that make this innovation possible in the first place.”
The National Association of Manufacturers is the largest manufacturing association in the United States, representing small and large manufacturers in every industrial sector and in all 50 states. Manufacturing employs 12.3 million men and women, contributes $2.33 trillion to the U.S. economy annually and has the largest economic multiplier of any major sector and accounts for 63% of private-sector research and development. The NAM is the powerful voice of the manufacturing community and the leading advocate for a policy agenda that helps manufacturers compete in the global economy and create jobs across the United States. For more information about the NAM or to follow us on Twitter and Facebook, please visit www.nam.org.